Literature DB >> 34320819

Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018.

Yoshihiro Tanaka1,2, Nilay S Shah1,3, Rod Passman1,3, Philip Greenland1,3, Donald M Lloyd-Jones1,3, Sadiya S Khan1,3.   

Abstract

Background Prevalence of atrial fibrillation (AF) continues to increase and is associated with significant cardiovascular morbidity and mortality. To inform prevention strategies aimed at reducing the burden of AF, we sought to quantify trends in cardiovascular mortality related to AF in the United States. Methods and Results We performed serial cross-sectional analyses of national death certificate data for cardiovascular mortality related to AF, whereby cardiovascular disease was listed as underlying cause of death and AF as multiple cause of death among adults aged 35 to 84 years using the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research. We calculated age-adjusted mortality rates per 100 000 population and examined trends over time, estimating average annual percentage change using the Joinpoint Regression Program. Subgroup analyses were performed by race-sex and across 2 age groups (younger: 35-64 years; older: 65-84 years). A total of 276 373 cardiovascular deaths related to AF were identified in the United States between 2011 and 2018 in decedents aged 35 to 84 years. Age-adjusted mortality rate increased from 18.0 (95% CI, 17.8-18.2) to 22.3 (95% CI, 22.0-22.4) per 100 000 population between 2011 and 2018. The increase in age-adjusted mortality rate (average annual percentage change) between 2011 and 2018 was greater among younger decedents (7.4% per year [95% CI, 6.8%-8.0%]) compared with older decedents (3.0% per year [95% CI, 2.6%-3.4%]). Conclusions Cardiovascular deaths related to AF are increasing, especially among younger adults, and warrant greater attention to prevention earlier in the life course.

Entities:  

Keywords:  United States; atrial fibrillation; cardiovascular deaths

Year:  2021        PMID: 34320819     DOI: 10.1161/JAHA.120.020163

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  9 in total

1.  Toward ECG-based analysis of hypertrophic cardiomyopathy: a novel ECG segmentation method for handling abnormalities.

Authors:  Kasra Nezamabadi; Jacob Mayfield; Pengyuan Li; Gabriela V Greenland; Sebastian Rodriguez; Bahadir Simsek; Parvin Mousavi; Hagit Shatkay; M Roselle Abraham
Journal:  J Am Med Inform Assoc       Date:  2022-10-07       Impact factor: 7.942

Review 2.  Atrial Fibrillation and Cancer Patients: Mechanisms and Management.

Authors:  David L Madnick; Michael G Fradley
Journal:  Curr Cardiol Rep       Date:  2022-08-17       Impact factor: 3.955

Review 3.  The need for increased pragmatism in cardiovascular clinical trials.

Authors:  Muhammad Shariq Usman; Harriette G C Van Spall; Stephen J Greene; Ambarish Pandey; Darren K McGuire; Ziad A Ali; Robert J Mentz; Gregg C Fonarow; John A Spertus; Stefan D Anker; Javed Butler; Stefan K James; Muhammad Shahzeb Khan
Journal:  Nat Rev Cardiol       Date:  2022-05-17       Impact factor: 49.421

4.  Association between complete right bundle branch block and atrial fibrillation development.

Authors:  Fu-Tao Zhang; Xiao-Jie Liu; Dan-Qing Zhao; Jin-Tao Wu; Lei-Ming Zhang; Juan Hu; Xian-Wei Fan; Hai-Tao Yang; Li-Jie Yan; Jing-Jing Liu; Shan-Ling Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-05-14       Impact factor: 1.485

Review 5.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

6.  Intermittent trapping of spiral waves in a cardiac model.

Authors:  Wouter-Jan Rappel
Journal:  Phys Rev E       Date:  2022-01       Impact factor: 2.707

7.  Characterization of baseline clinical factors associated with incident worsening kidney function in patients with non-valvular atrial fibrillation: the Hokuriku-Plus AF Registry.

Authors:  Kenshi Hayashi; Yoshihiro Tanaka; Toyonobu Tsuda; Akihiro Nomura; Noboru Fujino; Hiroshi Furusho; Norihiko Sakai; Yasunori Iwata; Soichiro Usui; Kenji Sakata; Takeshi Kato; Hayato Tada; Takashi Kusayama; Keisuke Usuda; Masa-Aki Kawashiri; Rod S Passman; Takashi Wada; Masakazu Yamagishi; Masayuki Takamura
Journal:  Heart Vessels       Date:  2022-10-17       Impact factor: 1.814

8.  PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.

Authors:  Xiao-Juan Guo; Xing-Biao Qiu; Jun Wang; Yu-Han Guo; Chen-Xi Yang; Li Li; Ri-Feng Gao; Zun-Ping Ke; Ruo-Min Di; Yu-Min Sun; Ying-Jia Xu; Yi-Qing Yang
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

9.  Combined impact of elevated arterial stiffness and left ventricular filling pressure on outcomes after off-pump coronary artery bypass grafting.

Authors:  Jae-Sung Choi; Se Jin Oh; Sohee Oh
Journal:  J Cardiothorac Surg       Date:  2022-10-02       Impact factor: 1.522

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.